DFX Intelligence
RIA Intelligence
Registered investment advisers, the advisors registered through them, the capital they report, the private vehicles they run and the people who own them, as a graph with a filing date behind every number. RAUM is what the adviser filed, a move is two registration dates, and a class is a rule you can read.
Private fund
New Leaf Biopharma Opportunities II, L.P.
Gross asset value
$130M
as of Mar 28, 2024; not a fund size
Peak GAV
$156M
highest filing
Owners
9
beneficial owners reported
Minimum investment
n/a
as reported
Adviser and related own
1%
of the fund
Owned by funds
0%
fund-of-funds interests
Non-US owners
0%
Reported
14 filings
Mar 29, 2019 to Mar 28, 2024
Reporting history
one row per Form ADV filing
Gross asset value$130M as of Mar 28, 2024
Mar 29, 2019$73.8M then
Owners9 as of Mar 28, 2024
Mar 29, 20199 then
Structure
- Exclusion
- 3(c)(7), qualified purchasersreported
- Master or feeder
- standalonereported
- Fund of funds
- noreported
- Organized in
- Delaware, United Statesreported
- Clients solicited
- noreported
- Form D file number
- 021-310283reportedthe join to the Form D offering
Custodians
Schedule D 7.B.(1).A.25, latest filing
- Banc Of California (Formerly Pacwest Bank)Durham, North Carolina
- Citibank NaNew York, New York
- Goldman Sachs & Co. LLCNew York, New York
- Pershing LLCNew York, New York
Across DFX
shared identifiers only
- NEW Leaf Biopharma Opportunities II, L.P. · peshared adv fund id
- NEW Leaf Biopharma Opportunities II, L.P. · vcshared adv fund id
Provenance
- Source
- Form ADV Schedule D 7.B.(1), every filing 2011 to 2024reportedadviserinfo.sec.gov
- Status
- on the adviser's latest filing in the extractderived
- Share
- 1.0%reportedadviser and related persons